Boothbay Fund Management’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.56M | Buy |
71,051
+9,963
| +16% | +$359K | 0.05% | 319 |
|
|
2025
Q1 | $2.41M | Sell |
61,088
-24,272
| -28% | -$957K | 0.06% | 298 |
|
|
2024
Q4 | $2.57M | Buy |
+85,360
| New | +$2.57M | 0.06% | 310 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1841 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2014 |
|
|
2022
Q1 | – | Sell |
-11,816
| Closed | -$225K | – | 2177 |
|
|
2021
Q4 | $225K | Buy |
11,816
+647
| +6% | +$12.3K | 0.01% | 1267 |
|
|
2021
Q3 | $372K | Buy |
11,169
+401
| +4% | +$13.4K | 0.01% | 1016 |
|
|
2021
Q2 | $418K | Buy |
10,768
+6,549
| +155% | +$254K | 0.01% | 956 |
|
|
2021
Q1 | $203K | Buy |
+4,219
| New | +$203K | 0.01% | 1124 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1266 |
|
|
2020
Q1 | – | Sell |
-52,426
| Closed | -$582K | – | 964 |
|
|
2019
Q4 | $582K | Buy |
+52,426
| New | +$582K | 0.05% | 381 |
|
|
2019
Q3 | – | Sell |
-59,934
| Closed | -$518K | – | 818 |
|
|
2019
Q2 | $518K | Buy |
+59,934
| New | +$518K | 0.05% | 319 |
|
|
2019
Q1 | – | Sell |
-21,772
| Closed | -$89K | – | 792 |
|
|
2018
Q4 | $89K | Sell |
21,772
-18,093
| -45% | -$74K | 0.01% | 485 |
|
|
2018
Q3 | $223K | Buy |
+39,865
| New | +$223K | 0.02% | 502 |
|